✦ LIBER ✦

Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer

✍ Scribed by Zhan, Yang; Cao, Bo; Qi, Yanfeng; Liu, Shuang; Zhang, Qi; Zhou, Weidong; Xu, Duo; Lu, Hua; Sartor, Oliver; Kong, Wei; Zhang, Haitao; Dong, Yan

Book ID: 120975821
Publisher: John Wiley and Sons
Year: 2013
Tongue: French
Weight: 467 KB
Volume: 133
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.28202

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CLINICAL STUDY OF MDV3100 IN PROGRESSIVE

CLINICAL STUDY OF MDV3100 IN PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

✍ Scher, Howard I; Beer, Tomasz; Higano, Celestia; Efstathiou, Eleni; Anand, Aseem 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 48 KB

Antitumour activity of MDV3100 in castra

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

✍ Howard I Scher; Tomasz M Beer; Celestia S Higano; Aseem Anand; Mary-Ellen Taplin 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 421 KB

Antitumour activity of MDV3100 in castra

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

✍ Kibel, A.S. 📂 Article 📅 2011 🏛 Elsevier Science ⚖ 44 KB

Re: Antitumour Activity of MDV3100 in Ca

Re: Antitumour Activity of MDV3100 in Castration-Resistant Prostate Cancer: A Phase 1–2 Study

✍ Kurt Miller 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Enzalutamide (formerly MDV3100) as a new

Enzalutamide (formerly MDV3100) as a new therapeutic option for men with metastatic castration-resistant prostate cancer

✍ Aragon-Ching, Jeanny B 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

160 POSTER Phase I-II study of MDV3100 i

160 POSTER Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials Consortium

✍ H. Scher; T. Beer; C. Higano; C. Logothetis; J. Shelkey; D. Hung; M. Hirmand; S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB